Pyrido [2, 3-d] pyrimidines and their use as kinase inhibitors

Details for Australian Patent Application No. 2007311480 (hide)

Owner GPC Biotech Inc.

Inventors Smith, Chase; Murthi, Krishna; Casaubon, Rebecca; Kluge, Arthur F.

Agent Watermark

Pub. Number AU-A-2007311480

PCT Pub. Number WO2008/047307

Priority PCT/ US2007/013299 06.06.07 US; 06122344.2 16.10.06 EP

Filing date 16 October 2007

Wipo publication date 24 April 2008

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

14 May 2009 PCT application entered the National Phase

  PCT publication WO2008/047307 Priority application(s): WO2008/047307

6 September 2012 Assignment before Grant

  GPC Biotech AG; GPC Biotech Inc. The application has been assigned to Forma Therapeutics, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007311485-Hydrogen production from formic acid

2007311479-Device for regulating the level of a liquid in a boiler of a coffee machine